Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of FG-4592 in Subjects with Moderate Hepatic Impairment
NCT02161224Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of roxadustat in anemia (2 arms), sponsored by Astellas Pharma. Primary endpoints: Area Under the Concentration-Time Curve Extrapolated to Infinity at Day 7 and Maximum Concentration at Day 7. Started Sep 2013; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02161224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02161224.